News

MUST READS 

USA2 SPOTLIGHT  

Must Listen: On Wednesday December 14, 2016 at 3PM EST Phyllis Barkman Ferrell, Vice President and GBD Leader of Global Alzheimer's Disease Platform Team at Eli Lilly, will offer thoughts on Lilly’s Phase III Solanezumab Trial. Details on how to listen in below. 

Webex:

MUST READS 

MUST READS 

USA2 SPOTLIGHT 

Pages

^ Back to Top